Healthcare and Life Sciences

Format: 2017-01-21
Format: 2017-01-21
November 25, 2016 | 124 Pages | SKU: IRTNTR10904

Overview of the global next-generation biologics market

According to the market research analysts at Technavio, the next-generation biologics market is anticipated to witness staggering growth and will post a staggering CAGR of more than 14% during the forecast period. The increasing demand for antibody drug conjugates (ADCs) is one of the major factors driving this market’s growth. ADCs are highly effective cytotoxic drugs linked to an mAbs. These drugs have shown to be potent and efficient in treating diseases, including cancers and hematological malignancies. Therefore, in the recent years, antibodies have become the preferred choice to treat respiratory, oncology, and inflammatory diseases. The use of ADCs, including radioimmunotherapy and antibody-directed enzyme prodrug therapy, has increased significantly. The augmented use of these antibodies in drug development increases revenue generation in the global next-generation biologics market, thereby contributing to market growth.

One of the recent trends gaining traction in the market is the emergence of targeted and combination therapies for the treatment of various diseases such as viral infections and cancer. This is mainly because targeted therapies have fewer side effects than conventional non-targeted therapies. Combination therapies work by targeting multiple mechanisms simultaneously. Targeting multiple pathways in diseases such as cancer, reduce the risk of developing treatment-resistant disorders. As a result, combination therapies, which target distinct mechanisms, are highly efficacious in treating various diseases, which will boost this market’s growth over the next four years.


November 24, 2016 | 99 Pages | SKU: IRTNTR10913

Overview of the global gastrointestinal stents market

The global gastrointestinal stents market is anticipated to grow at a steady rate and will post a CAGR of close to 4% during the forecast period. The growing preference for minimally invasive (MI) procedures will drive the growth prospects for the global industrial castings market during the forecast period. Generally, MI surgeries have low-risk complications and other benefits such as reduced costs, shorter hospital stay, faster recovery, lesser pain, fewer post-surgery infections, reduced incision marks, bleeding control, minimal complications, and heightened accuracy. Furthermore, MI techniques are highly preferred by the patients suffering from gastrointestinal diseases. For instance, a minimally invasive surgery is performed on stenosis using non-vascular stents. The gastrointestinal stent interventions do not involve any blood vessels. In addition, the imaging technologies are used to guide instruments inside the body by the surgeons without any surgery. Also, with the advent of non-vascular intervention for stenosis, the number of surgical procedures conducted each year to treat various vascular ad non-vascular diseases has increased. Moreover, improvements made in the equipment handling has transformed surgical procedures by providing better flexibility, support, and tracking of the stent during the procedure.

In terms of geography, the Americas occupied the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major reasons responsible for the market’s growth in the region is the high incidence of gastrointestinal disorders and chronic diseases such as colorectal cancer, rectal cancer, and severe abdominal diseases medical conditions. Another factor spurring this growth is the rapid shift from open surgical therapy to endovascular procedures with technologically advanced devices.


November 24, 2016 | 87 Pages | SKU: IRTNTR10903

Overview of the travel vaccines market

Technavio’s market research analysts have predicted that the global travel vaccines market is likely to witness fast-paced growth and will post a CAGR of close to 7% during the forecast period. The introduction of additional age group coverage is one of the primary factors driving this market’s growth. While approving a vaccine, the regulatory authorities also specify the age group approved for receiving the vaccine. This age group is specified on the vaccine label and is based on the efficacy and safety results obtained from clinical trials conducted using individuals from these age groups. Label expansion to include additional age groups approved for immunization requires additional regulatory approval. These approvals are based on the additional clinical trials conducted using individuals from additional age groups. The increase in approvals for additional age group coverage will increase the patient population for the vaccine, thereby propelling this market’s growth in the coming years.

One of the latest trends gaining traction in the market is the introduction of combination vaccines for travelers. Combination vaccines for immunizing travelers target multiple causative agents, which helps in the prevention of infectious diseases such as meningococcal disease, Japanese encephalitis, and hepatitis A infection. Moreover, combination vaccines eliminate the need for administering separate vaccines. For instance, pediatric hexavalent combination vaccine V419 is currently under review by the US FDA and MenABCWY polysaccharide conjugated vaccine is currently under Phase II stage of development for the prevention of meningococcal infections.


November 23, 2016 | 95 Pages | SKU: IRTNTR10885

Overview of the global gynecology robotic surgery market

The global gynecology robotic surgery market is anticipated to grow at a steady rate and will post a CAGR of more than 10% during the forecast period. The increasing preference for minimally invasive surgery (MIS) will drive the growth prospects for the global gynecology robotic surgery market during the forecast period. This growing preference for minimally invasive surgeries has resulted in the high adoption of robotic-assisted techniques. Some of the factors that encourage the adoption of MIS across the globe are the reduced recovery time, hospital stay, and postoperative pain. The robotic approach towards the complicated surgeries allow precise movement of instruments and give a better view of the targeted area in comparison to other conventional techniques. Consequently, robotic surgeries are gaining traction in the market, especially for gynecological applications. One of the major factors that drive the market’s growth is the associated patient satisfaction that encourages the manufacturers to develop more advanced robotic equipment.

In terms of geography, the Americas accounted for the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major factors responsible for the market’s growth in the region is the high occurrence of hysterectomies, malignant, and benign ovarian cancer cases. Another factor that drives the market’s growth in the region is the growing adoption of robotic surgery that indicates an increase in the market opportunity. Some of the companies such as the Titan Medical and OmniGuide will fuel the market’s growth.

Competitive landscape and key vendors

The market witnesses an intensively competitive environment due to the presence of Tier 1, Tier 2 companies and small companies. With the rising demand, many companies are developing and


November 22, 2016 | 82 Pages | SKU: IRTNTR10866

Overview of the lithotripters market

According to the market research analysts at Technavio, the global lithotripters market is anticipated to witness steady growth and will post a CAGR of over 2% during the forecast period. The growing demand for minimally invasive procedures is a primary factor driving this market’s growth. Minimally invasive procedures have several advantages over regular surgeries, such as minimal scarring, better surgical outcomes, reducing associated risks, and minimized procedure time without the need for multiple return visits. Moreover, since these procedures are mainly performed in ASCs, they offer greater comfort and have faster recovery time than conventional surgical procedures. The extracorporeal shock wave lithotripter (ESWL) percutaneous nephrolithotomy procedures commonly use MI techniques for kidney stone access, disintegration, and removal. Furthermore, MI techniques are increasingly used to manage cancer tumors that include tumors in the kidneys, lungs, liver, and musculoskeletal system. These minimally invasive surgical procedures reduce the risk of infection and are less painful compared to traditional open surgeries, which will propel the growth of the lithotripters market over the coming years.

One of the latest trends spurring this market’s growth is the growing adoption of percutaneous nephrolithotomy (PCNL) devices for the removal of kidney stones that are more than 2-cm in size and present near the pelvic region. The PCNL technique removes certain stones in the kidney or upper ureter through a small puncture in the skin. The technique considerably minimizes incision size, pain, blood loss, blood transfusions and reduces hospitalization time. New stone retrieval and


November 21, 2016 | 91 Pages | SKU: IRTNTR10853

Overview of the dental cone-beam computed tomography (CBCT) market

Extensive research carried out by the analysts at Technavio has shown that the global dental cone-beam computed tomography (CBCT) market will witness impressive growth and post a staggering CAGR of more than 12% over the forecast period. With the growing number of dental schools and dentists, the market for dental CBCT is expected to have a positive outlook in the coming years. The increasing number of dental specialty hospitals and laboratories in the Americas and Europe is leading to the augmented adoption of CBCT in these regions. In the Americas, the market’s growth is high as public-private dental schools are increasing. With the increasing dental problems in the region, there is a high requirement for dentists, which can be fulfilled by the growth of dental schools in the market.

In terms of geography, the Americas led the global dental CBCT market during 2015 and is likely to dominate the market over the next four years. The growth of this market in the region is attributed to the increasing number of dental implant procedures and radical improvements in dentomaxillofacial surgeries in the Americas. The use of dentomaxillofacial radiology has increased after the introduction of CBCT application in dental services as it helps in soft tissue examination, temporomandibular joint examination, and plaque detection. The extensive application of CBCT will lead to its increased adoption in the region, especially in countries like the US and Canada.

Competitive landscape and key vendors

The global


Pages